← Back to Search

Orthopedic Implant

Triathlon Tritanium Knee for Knee Replacement Surgery

N/A
Waitlist Available
Led By David Heekin, MD
Research Sponsored by Stryker Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights

Study Summary

This trial will compare the rate of aseptic loosening of the tibial baseplate in the Triathlon Tritanium Knee to rates reported in the literature.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Knees With Cementless Application That Had Successful Primary Total Knee Replacement With the Triathlon Tritanium Total Knee System
Secondary outcome measures
Compare 2011 Knee Society Score (KSS) Scores Between Both Groups
Compare Oxford Knee Score (OKS) Scores Between Both Groups
Compare Short Form-12 (SF-12) Scores Between Both Groups
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Triathlon Tritanium KneeActive Control1 Intervention
Cases are enrolled in the Cohort 1 (cementless) until a total of 356 cases receive the Triathlon Tritanium Tibial Baseplate, Triathlon Tritanium Patella, Triathlon CR or PS Beaded Femur with PA and the Triathlon Tibial Insert. All components in this cohort must used in a cementless application.
Group II: Triathlon KneeActive Control1 Intervention
Enrollment in Cohort 2 (cemented) will begin upon completion of enrollment into the Cohort 1 (cementless), and will continue until a total of 144 cases receive the Triathlon Tibial Tray, Triathlon Patella, Triathlon CR or PS Femur and Triathlon Tibial Insert. All components in this cohort must be used in a cemented application.

Find a Location

Who is running the clinical trial?

Stryker OrthopaedicsLead Sponsor
77 Previous Clinical Trials
19,553 Total Patients Enrolled
David Heekin, MDPrincipal InvestigatorHeekin Clinic
Kipling Sharpe, MDPrincipal InvestigatorOrthoArizona

Media Library

Triathlon Knee (Orthopedic Implant) Clinical Trial Eligibility Overview. Trial Name: NCT02155712 — N/A
Knee Replacement Surgery Research Study Groups: Triathlon Tritanium Knee, Triathlon Knee
Knee Replacement Surgery Clinical Trial 2023: Triathlon Knee Highlights & Side Effects. Trial Name: NCT02155712 — N/A
Triathlon Knee (Orthopedic Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02155712 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to register for this clinical trial?

"This medical trial is open to 588 patients aged between 18 and 75 who have arthroplasty. To be considered for the study, they must also meet additional criteria such as being able to adhere to post-operative evaluations and rehabilitation, having signed an IRB/EC approved consent form, not currently pregnant (if female), possessing a diagnosis of NIDJD and being suitable candidates for primary cementless total knee replacement with resurfaced patella."

Answered by AI

Does the age restriction for participants in this trial extend beyond forty years old?

"According to the entry requirements for this trial, participants must be of age 18 or more and no older than 75."

Answered by AI

In how many locations can this clinical trial be accessed?

"Heekin Clinic in Jacksonville, OrthoArizona in Gilbert and St. Joseph Mercy Health System in Ypsilanti are amongst the 10 enrolment centres for this medical trial, with other sites across America also contributing to its recruitment drive."

Answered by AI

Is enrollment currently available for this scientific investigation?

"Unfortunately, this clinical trial is not actively searching for participants. The protocol was first published on October 1, 2014 and saw its latest update on August 26th 2022. However, there are 29 other trials that are currently recruiting patients at the moment."

Answered by AI
~65 spots leftby Apr 2025